Oligonucleotide delivery: a patent review (2010 – 2013)
作者： Santiago Grijalvo , Anna Aviñó , Ramon Eritja
DOI: 10.1517/13543776.2014.915944
关键词:
摘要: Introduction: The use of aptamers, antisense technology and RNA interference has allowed nucleic acids to be considered as promising alternatives to classical drugs. However, nucleic …
informahealthcare.com参考文章(106)
Bilal Ghosn, Krishnendu Roy, Sudhir Kasturi, Modified Polysaccharide-Based Delivery of Nucleic Acids ,(2010)
David A. Scheinberg, Michael R. Mcdevitt, J. Justin Mulvey, Carlos H. Villa, Targeted self-assembly 0f functionalized carbon nanotubes on tumors ,(2012)
Andrew Vaillant, Michel Bazinet, Oligonucleotide chelate complex-polypeptide compositions and methods ,(2013)
Lali K. Medina-Kauwe, Targeted delivery system ,(2010)
Tariq M. Rana, Delivery of agents using interfering nanoparticles ,(2011)
José Carlos Perales Losa, Brendan Manning, Ramón Eritja Casadellá, Ana Aviñó Andrés, Montserrat Terrazas Martínez, Álvaro Somoza Calatrava, Sandra Milena Ocampo, Modified oligonucleotides as regulators of gene expression ,(2010)
Brian Kaspar, Arthur Burghes, Paul Porensky, Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease ,(2012)
Ülo Langel, Piret Arukuusk, Nikita Oskolkov, Dana Maria Copolovici, A system for cargo delivery into the cells ,(2012)
David L. Mcelligott, Enhanced biodistribution of oligomers ,(2012)
Robert B. Jenkins, Gobinda Sarkar, Geoffry L. Curran, Peptide-mediated delivery of active agents across the blood-brain barrier ,(2012)